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and §School of Pharmacy, University of Nottingham, Nottingham, United KingdomABSTRACT Raman microspectroscopy (RMS) was used to detect and image molecular markers specific to cardiomyocytes
(CMs) derived from human embryonic stem cells (hESCs). This technique is noninvasive and thus can be used to discriminate
individual live CMs within highly heterogeneous cell populations. Principal component analysis (PCA) of the Raman spectra was
used to build a classification model for identification of individual CMs. Retrospective immunostaining imaging was used as the
gold standard for phenotypic identification of each cell. We were able to discriminate CMs from other phenotypes with >97%
specificity and >96% sensitivity, as calculated with the use of cross-validation algorithms (target 100% specificity). A compar-
ison between Raman spectral images corresponding to selected Raman bands identified by the PCAmodel and immunostaining
of the same cells allowed assignment of the Raman spectral markers. We conclude that glycogen is responsible for the discrim-
ination of CMs, whereas myofibril proteins have a lesser contribution. This study demonstrates the potential of RMS for allowing
the noninvasive phenotypic identification of hESC progeny. With further development, such label-free optical techniques may
enable the separation of high-purity cell populations with mature phenotypes, and provide repeated measurements to monitor
time-dependent molecular changes in live hESCs during differentiation in vitro.INTRODUCTIONStem cell (SC) therapy is widely acknowledged as a key
medical technology of the 21st century. SCs have enormous
potential for use in cell-replacement therapies for age-related
illnesses such as Alzheimer’s disease and Parkinson’s
disease, as well as diabetes and cardiovascular disorders
(1), and are a reliable source of cells for tissue engineering
(2). Furthermore, SC-seeded scaffolds may provide an
unlimited supply of grafts to replace and repair diseased
tissues (3). Human embryonic SCs (hESCs) are derived
from the inner cell mass of blastocyst-stage embryos (4).
They are pluripotent by nature, and virtually all cell types
can be derived after differentiation, including cardio-
myocytes (CMs) (5). However, the ability to control the
differentiation status and phenotypic purity of hESC-derived
cell populations is a critical factor in addressing the effi-
ciency and safety of SC therapies. It has been reported that
excessive proliferation after transplantation of cells with
unwanted phenotypes can cause tissue overgrowth and tumor
formation (6).
However, the current conditions under which specific cell
types are derived remain suboptimal, and generally result in
low yields of the desired differentiated lineages within
highly heterogeneous populations that are not suitable for
clinical use due to the presence of mainly unwanted cell
types. This current limitation in the delivery of validated
hESCs suitable for clinical applications highlights theSubmitted August 25, 2010, and accepted for publication November 23,
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0006-3495/11/01/0251/9 $2.00immediate need for noninvasive optical techniques that
can phenotypically identify live cells within highly hetero-
geneous populations.
In this study, we developed a technique based on Raman
microspectroscopy (RMS) to identify lineage-specific
molecular markers for live cardiomyocytes (CMs) derived
from hESCs in vitro. Our basic hypothesis was that RMS
could be used to measure intrinsic chemical differences
among different cell types without the use of labels or other
invasive procedures. Indeed, chemical differences among
cell types are expected, as differentiated cells are special-
ized to perform specific functions and consequently produce
specific biochemicals. For example, CMs contain a large
number of myofibrils, b-cells secrete insulin, and neurons
produce neurotransmitters.
Compared with other techniques, Raman spectroscopy
has several unique advantages. Conventional cell biology
assays (e.g., polymerase chain reaction and Western blot-
ting) are invasive and not suitable for characterizing hetero-
geneous cell populations because they require a large
number of cells, and the results represent averages over
entire cell populations. Fluorescence- and magnetic-acti-
vated cell sorting approaches rely on lineage-specific
surface markers that are expressed on the cell membrane
(7,8). However, there are numerous cases, including that
of CMs, in which most of the lineage-specific markers
used in these techniques are not expressed on the cell
surface. Detection thus requires fixation and permeabiliza-
tion, rendering the cell unusable in a clinical environment.
Therefore, these techniques can only be used to identify
a limited number of viable cell types (e.g., hematopoietic
lineages). To circumvent the difficulties of antibody-baseddoi: 10.1016/j.bpj.2010.11.043
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express markers (e.g., green fluorescent protein) from
lineage-specific promoters. However, recently developed
strategies to enrich hESC-derived CMs to >90% purity
(9,10) involve complex genetic modifications of cells, and
thus are not ideal for clinical applications.
Recent studies have demonstrated the potential of RMS
for measuring the chemical properties of live cells (11).
This technique combines the high chemical specificity of
Raman spectroscopy with the high spatial resolution of
optical microscopy to provide detailed molecular informa-
tion about complex biological samples, including cells
(12). Because RMS has only a minimal background signal
from water, it allows repeated observations of viable cells
maintained under physiological sterile conditions, which is
difficult to achieve by other molecular vibrational tech-
niques (13,14).
The high spatial resolution of RMS has enabled the anal-
ysis of organelles (15) and the distribution of proteins (16),
apoptotic bodies (17), lipid vesicles (18), and lipid deposits
(19) in individual fixed cells. Other applications to live cells
maintained in buffer solutions include analysis of subcel-
lular components, such as the nucleus (12), heme moieties
in erythrocytes (20), and cytotoxic granules in human killer
T cells (21). RMS has also been used to detect biochemical
changes related to various cellular processes, including
differentiation (22) and interactions with drugs (23,24)
and toxins (25). More recently, time-course RMS imaging
has been used for short time periods (20 min) on cells in
saline buffers (26) and on cells maintained under physiolog-
ical conditions for extended periods of time (6 h) to monitor
biochemical changes related to apoptosis (27).
In one study (28), the high chemical specificity of RMS
enabled detection of a decrease in RNA abundance during
in vitro differentiation of murine ESCs, and another (29)
showed that the contribution of nucleic acids was higher
in the Raman spectra of undifferentiated murine ESCs
compared with differentiated cells. Similar results were
also found in more recent studies using hESCs (30).
A comparison between different age groups of rhesus
monkey mesenchymal cells derived from bone marrow
indicated a higher DNA and lower protein contribution in
the Raman spectra of fetal cells compared with juvenile
cells (31). In a recent study (32), investigators attempted
to discriminate between undifferentiated hESC and hESC-
derived CMs by RMS; however, although they were able
to identify spectral differences, mainly related to nucleic
acids, the reported discrimination accuracy for CMs against
undifferentiated hESCs was only 66%.
In this study, we tackled for the first time (to our knowl-
edge) the challenge of detecting noninvasive molecular
markers specific to hESC-derived CMs. Such markers can
be used to identify CMs from other differentiated cells
within highly heterogeneous cell populations derived from
hESCs. We analyzed individual live cells by RMS andBiophysical Journal 100(1) 251–259carried out retrospective phenotypic identification of all
cells by the gold-standard method of immunofluorescence
imaging integrated with the Raman microscope. We evalu-
ated the effects of laser irradiation on the cells by perform-
ing a beating frequency analysis on individual CMs. The
Raman spectra of the cells were analyzed by means of
multivariate statistical methods, with the aim of developing
high-accuracy models for discriminating CMs from other
unwanted cell types. The spectral markers identified in these
models were then correlated with cellular biochemical
changes related to differentiation toward the cardiac pheno-
type. The distribution of these spectral markers in individual
live cells was mapped and compared with fluorescence
images of the same cells to enable identification of the
chemicals responsible for discrimination of CMs.MATERIALS AND METHODS
Materials and general cell culture
All tissue culture reagents were purchased from Invitrogen (Paisley, UK)
and chemicals were obtained from Sigma-Aldrich (Poole, UK) unless
otherwise stated. Mouse embryo fibroblasts and hESC cultures were main-
tained at 37C, 5% CO2, in a humidified atmosphere. The medium was
changed daily for hESC culture and every 3–4 days during differentiation.
Purified chemicals used for comparison with Raman spectra of cells (i.e.,
myosin heavy chain from rabbit muscle (M7659-1MG), Troponin T from
human heart (T0175-50UG), and glycogen from Mytilus edulis (G1767-
1VL)) were purchased from Sigma-Aldrich. All chemicals were used
without further purification.hESC culture and differentiation
The hESC line HUES7 was cultured in feeder-free conditions in condi-
tioned medium in a Matrigel-coated flask and cultured using trypsin
passaging between passages 17–35. Differentiation was achieved by forced
aggregation of defined numbers of hESCs as described previously (5)
(see the Supporting Material). Beating clusters containing CMs and non-
CMs were manually dissected, washed in phosphate-buffered saline
(PBS), and then incubated for 30 min at room temperature in buffer
1 (120 mM NaCl, 5.4 mM KCl, 5 mM MgSO4, 5 mM sodium pyruvate,
20 mM taurine, 10 mM HEPES, 20 mM glucose, pH 6.9), for 45 min
at 37C in buffer 2 (120 mM NaCl, 5.4 mM KCl, 5 mM MgSO4, 5 mM
sodium pyruvate, 20 mM taurine, 10 mM HEPES, 0.3 mM CaCl2,
20 mM glucose, 1 mg/mL collagenase B, pH 6.9), and for 1 h at room
temperature in buffer 3 (85 mM KCl, 5 mM MgSO4, 5 mM sodium pyru-
vate, 20 mM taurine, 1 mM EGTA, 5 mM creatine, 30 mM K2HPO4,
20 mM glucose, 1 mg/mL Na2ATP, pH 7.2). Finally, cell clusters were
dissociated by repeated pipetting through a P1000 tip, and the liberated
cells were seeded in dialyzed fetal bovine serum in purpose-built cell cham-
bers for the Raman measurements.Immunostaining of cells
Immediately after the Raman measurements were obtained, the samples
were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton-
X100, and then incubated with mouse monoclonal anti-a-actinin (1:800;
Sigma) for 1 h at room temperature. Cell nuclei were stained with 40,6-dia-
midino-2-phenylindole (DAPI, 100 ng/mL) at 1:1000 dilution in PBS for
5 min at room temperature. For glycogen staining, a periodic acid-Schiff
(PAS) kit (Sigma-395B) was used. After the cells were stained with
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periodic acid solution for 5 min. The samples were rinsed three times
with deionized water and treated with Schiff’s reagent for 15 min. They
were then washed with deionized water for 10 min and counterstained
with hematoxylin for 90 s. The samples were rinsed again with deionized
water for evaluation under a light microscope.Analysis of beating frequency for individual CMs
A beating frequency analysis was carried out on individual beating CMs
maintained on the Raman microscope under conditions similar to those
used for the Raman measurements. Videos recorded under white-light
illumination were analyzed using routines developed in MATLAB (The
MathWorks, Natick, MA). First, all video frames were converted into gray-
scale and only pixels that contained the cell were selected for analysis (typi-
cally ~400 pixels). To increase the accuracy of the analysis method, we
increased the contrast between the lightest and darkest regions of a cell
by digitizing the intensity shifts at each pixel using a threshold value. We
obtained the beating frequency at each pixel of a cell by calculating the
Fourier transform of the time-dependent intensity shift at each individual
pixel. The beating frequency of the cell was then calculated as the mean
of the frequency values obtained at all pixels. Assuming that beating was
homogeneous within the cell, the digitizing threshold was selected as the
value that provided the smallest standard deviation (SD) between frequen-
cies measured at different pixels inside the cell. The SD was then used as
a measure of the error for the beating frequency.RMS measurements
Raman spectrawere recordedwith an in-house-built Ramanmicrospectrom-
eter optimized for live-cell studies. The instrument consisted of an inverted
microscope with a water-immersion objective (60/NA 0.90; Olympus,
Essex, UK), a spectrometer equippedwith an 830 lines/mmgrating, a cooled
deep-depletion back-illuminated CCD detector (Andor Technologies,
Belfast, UK), and a high-precision automated step-motor stage (Prior, Cam-
bridge, UK). The wave-number axis of the spectrometer was calibrated
before each experimentwith the use a standard Tylenol sample, and the spec-
tral resolution was ~1.5 cm1 in the 600–1800 cm1 region. The laser diode
(785 nm wavelength) had ~150 mW power (after objective), 2.2 mm beam
diameter, and beam quality factor M2 ¼ 1.7 (Toptica Photonics, Munich,
Germany). The laser spot diameter was calculated to be 2.3 mm.
Purpose-designed titanium cell chambers were built that incorporated
MgF2 coverslips (0.17 mm thick) at the bottom to enable acquisition of
Raman spectra of the cells. The Raman microscope was equipped with an
environmental enclosure (Solent, Segensworth, UK), which combined with
the inverted optical configuration allowed the cells to be maintained under
sterile physiological conditions (culture medium, 37C temperature, 5%
CO2).
We recorded the Raman spectra of CMs (50 cells) and non-CMs (40 cells)
for several months using >20 cell culture flasks, including cells at various
passages. For each cell population, both CMs and non-CMs were measured.
The Raman spectrum of each individual cell represented the average of
a total of 625 spectra that were measured at different positions inside the
cell by raster-scanning the cell through the laser focus in 2 mm steps (equiv-
alent to a grid of 25  25 points). The acquisition time at each position was
1 s. After the acquisition of Raman spectra was completed, the position
coordinates of each cell were recorded and the cells were fixed and prepared
for immunostaining (cardiac phenotype and cell nucleus). The cardiac
phenotype of the cells was established with the use of a wide-field fluores-
cence staining system integrated on the Raman microscope. We retroposi-
tioned each cell by using the cell coordinates (accuracy ~5 mm), which
allowed us to assign each individual cell to the CM or non-CM group.
We found that it was impractical to establish the exact phenotype of the
non-CMs by the immunostaining method.Data analysis and processing
Data preprocessing consisted of three steps: removal of spectra containing
cosmic rays, background subtraction, and normalization. Because 625
Raman spectra were acquired for each individual cell, the small fraction
of individual spectra that contained cosmic rays (typically <1%) could
be eliminated without affecting the outcome of the data analysis. The
average of the Raman spectra measured at points outside of the cell (auto-
matically identified using a PCA routine) represented the background spec-
trum (contributions from the culture medium, MgF2 coverslip, and
microscope objective). The Raman spectrum that was representative of
each cell was obtained by algebraic subtraction of the background spectrum
from the average of the Raman spectra at all positions inside the cell. All
Raman spectra were then normalized using the standard normal variance
method (zero mean and unity variance) (28).
The Raman spectra of the cells were analyzed by PCA using functions in
MATLAB. Raman spectral images corresponding to selected Raman bands
were obtained by calculating the area under the spectral bands after sub-
tracting the estimated local linear baselines and representing the integrated
intensity value at each measurement position in the cell.RESULTS AND DISCUSSION
Effect of laser irradiation on CMs:
analysis of beating frequency
It is well known that biomolecules are sensitive to light, and
exposure of cells to lasers can cause localized heating or
induce toxic photochemical reactions. Although lasers in
the visible range (400–600 nm) allow rapid measurement
of high-quality Raman spectra of fixed cells (15), such lasers
can induce cell damage even at low laser powers and short
exposure times (33). In contrast, when cells are irradiated
by lasers in the near-infrared region (700–1000 nm), they
can remain viable even after longer exposures at much
high laser power densities (34,35).
In a previous study on hESCs and hESC-derived CMs
(32), it was noted that, visually, laser exposure at 70 mW
for 5 min (785 nm laser) did not seem to affect the beating
of the hESC-CM clusters, and trypan blue viability tests
indicated that the cells remained viable. However, the exper-
iments presented in that work used a fivefold higher laser
power and fivefold longer acquisition time compared to
previous studies, as required to sample the entire volume
of the cell rather than to obtain single-point measurements.
Therefore, this longer laser exposure required a new evalu-
ation of the laser’s effect on cells to ensure that the proposed
RMS technique is noninvasive.
Because we observed no evident morphological changes
indicating necrosis or apoptosis after laser irradiation
(Fig. 1, A and B), we evaluated more subtle cellular changes
bymeasuring the beating frequency of individualCMs before
and 15 min after the Raman measurements. The beating
frequency before laser irradiation was found to be in the
0.75–1.75 Hz range (Fig. 1 C), in agreement with recent
reports for CMs (36). The mean SD values were ~24%, indi-
cating that the beating frequency can vary considerably
within individual CMs. Fig. 1 C shows that the mean changeBiophysical Journal 100(1) 251–259
FIGURE 1 Analysis of beating frequency of CMs before and after laser
irradiation, as required for collection of Raman spectra. (A and B) Phase-
contrast image before (A) and after (B) irradiation. (C) Initial frequencies
and frequency changes after laser irradiation. Error bars represent the vari-
ability in frequency measurement (SD) at various positions in each cell.
FIGURE 2 Typical immunostaining images of individual cardiomyo-
cytes (CM) (A) and non-cardiomyocyte (non-CM) (B) derived from hESCs:
cell nuclei DAPI (blue), cardiac a-actinin (red). (C) Raman spectra of the
same cells.
254 Pascut et al.in beating frequency of hESC-derived CMs after measure-
ment of Raman spectra was only 18%, which is lower than
the SD. Therefore, these results demonstrate that, apart
from not inducing cell death, laser irradiation (as required
for the acquisition of Raman spectra to phenotypically iden-
tify CMs) did not affect the beating frequency of the CMs.Molecular markers for phenotypic identification
of CMs
Fig. 2 presents immunofluorescence images and Raman
spectra of typical differentiated live cells derived from
hESCs. The immunostaining images of the cardiac pheno-
type (a-actinin) and cell nuclei (DAPI) for the same cells
highlight the high heterogeneity of the cell populations
derived from hESCs (see Fig. S1 for additional low-magni-
fication figures of cells derived from hESCs). Because the
percentage of CMs in the cell population was typically
<10%, retrospective phenotypic identification using the
gold-standard immunostaining assay for each individual
cell was essential. A recent RMS study that aimed to
discriminate hESC-derived CMs from undifferentiated
hESCs without using a gold-standard method for retrospec-
tive phenotypic identification of the CMs reported a modest
accuracy of 66% (32). The authors acknowledged that theBiophysical Journal 100(1) 251–259low accuracy might have been due to the high phenotypic
heterogeneity of the cell populations derived from hESCs.
Fig. 2 C shows that the sampling method used in this
study led to high signal/noise ratio Raman spectra that are
representative of the entire cell analyzed. Several spectro-
scopic features can be easily recognized in the Raman
spectra of both CMs and non-CMs that correspond to the
molecular vibrations of cellular biochemicals (i.e., nucleic
acids, protein, lipids, and carbohydrates) and are consistent
with previous reports on other cell types (11). To illustrate
the spectral differences, the average Raman spectra of
CMs (50 cells) and non-CMs (40 cells) derived from hESCs
are shown in Fig. 3. The computed SD spectra were also
included (gray lines) to show the intercellular variance
within each group of cells. The computed difference spec-
trum (DS; CMs minus non-CMs) is also presented in
Fig. 3, including the combined SD spectrum. Fig. 3 shows
that spectral differences between CMs and non-CMs can
be identified in several spectral regions. The first region is
825–950 cm1 and is associated with the molecular vibra-
tions of proteins, carbohydrates, and lipids. The second
region is 1035–1170 cm1 and is associated mainly with
the vibrations of carbohydrates, lipids, and nucleic acids.
The third region is the highly convoluted region between
1320 and 1420 cm1, where contributions are dominated
by proteins, carbohydrates, and nucleic acids. A more
detailed discussion on the molecular assignments of these
bands will be presented in the next section.
FIGURE 3 Average Raman spectra of CMs and non-CMs, and their
computed DS. SD lines represent the SD calculated at each wave number.
Shaded areas highlight the spectral regions that may be used for discrimi-
nation of CMs.
FIGURE 4 (A) First four PC loading spectra in the PCA of Raman
spectra of CMs and non-CMs. The variance captured by each PC is shown
in brackets. (B) Distribution of the scores corresponding to the first PC
(PC1) for CMs (circles) and non-CMs (squares).
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CMs include multiple Raman bands, a multivariate statis-
tical model has been developed for the discrimination of
CMs. PCA decomposes multivariate data sets in uncorre-
lated PCs in such a way that the first few components will
capture most of the variation present in the data set. PCA
has been used extensively in the study of Raman spectra
of cells, including ESCs (28,32).
Fig. 4 A shows that out of 90 PCs needed to identically
reconstruct the original data set, only the first four PCs
had a high signal/noise ratio and captured 86% of the vari-
ance between the Raman spectra of all cells, including CMs
and non-CMs. After we inspected individual PCs and their
contribution to the total variance, we concluded that using
only the first PC (PC1), accounting for 65% of the variance,
is adequate for class-discrimination purposes. It is also
important to note that the main spectral bands in PC1 are
also found in the computed DS between average Raman
spectra of CMs and non-CMs. The inclusion of PC2, PC3,
or PC4 (capturing 12.36%, 7.33%, and 2.15% of the vari-
ance, respectively) did not improve the discrimination
between CMs and non-CMs.
The probability distributions of the PC1 scores are pre-
sented in Fig. 4 B, which shows a clear distinction between
CMs and non-CMs. By selecting the boundary between the
two classes at the intersection of the two fitted probability
functions (Fig. 4 B), we find that the classification accuracy
of the PCA model has 96% sensitivity and 100% specificity.
(In this case, the specificity is the ability of Raman spectros-
copy to identify and exclude all non-CM cells, and the
sensitivity parameter represents the ability to correctly iden-
tify CMs.)
Although PCA has been successfully used to identify
Raman spectral bands that are able to discriminate CMs, thevalues for specificity and sensitivity give no indication about
the ability of these spectral markers to enable phenotypic
identification of new cells. To determine the true accuracy
for the phenotypic identification of CMs, we used cross-vali-
dation (CV) to determine the sensitivity and specificity
parameters for a certain target sensitivity or specificity. The
different CV methods can also be labeled with the percent-
ages corresponding to the data set splitting (where the first
figure refers to the fraction of the data set used to build the
classificationmodel, and the secondfigure represents the frac-
tion of the data set to which the model is applied). In leave-
one-outCV (LOOCV), all spectra except one are used to build
a model and then to classify the left-out spectrum. This
method is repeated so that each spectrum is predicted once.
The PCA model gives us the flexibility to set the classifi-
cation boundary between CMs and non-CMs to emulate
a realistic scenario in which we can target a highly specific
regime of 100% specificity, as required in regenerativeBiophysical Journal 100(1) 251–259
TABLE 1 Discrimination accuracy for CMs calculated by three CV methods
CV method Model target specificity Model sensitivity Prediction specificity Prediction sensitivity
70/30% 100% 96.255 2% 97.275 4% 96.675 3%
80/20% 100% 96.285 1.45% 96.795 6.75 96.305 5%
LOOCV 100% 96.085 0.29% 97.54 96.1
256 Pascut et al.medicine. This type of modeling is required to ensure that
no unwanted cells are predicted as CM, thus leading to
a lower-purity cell population. However, this regime may
lead to more CMs being misclassified as non-CMs, thus
decreasing the number of cells available for treatment.
The CV specificity and sensitivity for 70/30%, 80/20%,
and LOOCV calculated for target 100% specificity are
shown in Table 1. For the LOOCV, all possible permutations
were used to calculate the sensitivity and specificity because
the number of possible permutations was relatively small.
However, for the 70/30% and 80/20% methods, the number
of possible permutations was high, and therefore only 3000
randomly chosen combinations were used. The CV results
in Table 1 show that the Raman spectral bands determined
by PC1 provide >97% specificity and >96% sensitivity.
Table 1 also shows that the values for the predicted sensi-
tivity and specificity are independent of the CV method
used, demonstrating the robustness of the Raman spectral
markers. It is worth noting that by adjusting the classifica-
tions boundary, one can further improve the prediction spec-
ificity by up to 100%, albeit at the expense of lower
sensitivity.FIGURE 5 Comparison between the computed DS and selected chemi-
cals that are more abundant in CMs compared with other phenotypes.Imaging and assignment of the Raman spectral
markers
CMs are specialized to perform specific functions and
consequently express specific biochemicals to produce
a large number of myofibrils. Beating CMs also require
a higher amount of energy compared with other cell types,
and therefore they store larger amounts of glycogen. In addi-
tion to the high classification and discrimination ability
provided by assignment of the Raman bands identified by
the PCA model, this approach can also provide insight
into the chemical differences between CMs and non-CMs.
A comparison between the computed DS and the Raman
spectra of a few selected biochemicals known to be more
abundant in CMs (i.e., myosin, troponin, and glycogen) is
shown in Fig. 5. There is a striking similarity between the
Raman spectra of glycogen and DS, suggesting that
glycogen is one of the main contributors to the discriminant
factor between CMs and non-CMs. Several Raman bands
corresponding to glycogen (C-O-H ring vibrations at
860 cm1, C-O-C glycosidic bond vibrations at 938 cm1,
and C-C and C-O stretchings at 1084 cm1 and
1123 cm1) can be identified, whereas C-H deformation
vibrations contribute at 1340 cm1,1381 cm1, and
1450 cm1 (37). The presence of glycogen inside the CMsBiophysical Journal 100(1) 251–259has been well documented, as these cells have long been
used as a valid model of glycogen metabolism (38). Fig. 5
also shows that myosin and troponin have several bands
that overlap certain glycogen bands identified in the DS:
853 cm1 assigned to C-C and CH3 stretching vibrations
in lysine, aspartic acid, leucine, valine, and 936 cm1 asso-
ciated with C-C stretching of protein backbones (37).
However, the contribution of myosin and troponin to the
spectral marker is less evident than that for glycogen.
One of the main features of RMS is that it enables the
collection of Raman spectra from micrometric regions of
live cells. We used this feature to aid in the molecular
assignment of Raman spectral markers of CMs by observing
the spatial distributions of these biomolecules within
individual cells and comparing them with immunostaining
images. Fig. 6 compares the Raman spectral map of the
938 cm1 Raman band for a typical CM (Fig. 6 C) with
the immunostaining images for myofibrils (a-actinin;
Fig. 6 A) and glycogen (PAS; Fig. 6 B) of the same cell.
Fig. 6 C indicates that the molecules that contribute the
most to the identification of CMs are localized in the center
of this cell, at the same location where the PAS staining also
shows a significantly higher concentration of glycogen.
Fig. 6 D shows a typical Raman spectrum measured at
a position with a high abundance of both glycogen and
myofibrils (top spectrum, blue square). The Raman spec-
trum shows a very close similarity to the PC1 and pure
glycogen spectra in Fig. 5. On the other hand, the immunos-
taining for a-actinin (Fig. 6 A) suggests that myofibrils are
FIGURE 6 (A) Immunostaining for cardiac
phenotype (a-actinin, red) and cell nucleus
(DAPI, purple). (B) PAS staining for glycogen.
(C) Raman spectral image corresponding to the
938 cm1 band obtained from a typical CM. (D)
Selected Raman spectra at positions indicated by
the blue square and green star (acquisition time:
1 s per spectrum).
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central region. The bottom Raman spectrum in Fig. 6 D
(green star), measured at a position that is rich in myofibrils
but has a lower glycogen concentration, is similar to that of
myosin and troponin, with a strong band at 938 cm1 but no
band at 860 cm1. Therefore, the closer similarity between
the Raman map and glycogen staining combined with the
band assignment identification suggests that glycogen is
the main contributor to the Raman spectral marker of
hESC-derived CMs, whereas the proteins found in myofi-
brils have a lower contribution. It is well known that
glycogen is an integral part of cells in general. Therefore,
we cannot claim that glycogen is a general unique identifier
of the CM phenotype. However, the results obtained in this
study demonstrate that if hESCs are differentiated as
described, glycogen can provide a high accuracy for identi-
fication of CMs. Further studies will be necessary to achieve
a complete assignment of the Raman bands, which should
include relevant biomolecules isolated directly from
hESC-derived CMs. However, such an analysis was beyond
the scope of this work.Fig. 6 also highlights another important point: the high
intracellular chemical variability of the CMs, which led to
high variations in the Raman spectra measured at various
locations inside the cells. For example, although the two
spectra presented in Fig. 6 D correspond to two positions
only ~12 mm apart inside the cell, their spectral features are
completely different. Given that typical cells have diameters
of ~50–60 mm, and the laser spot is ~2.3 mm, it was important
to ensure that the cells were raster-scanned through the laser
spot (step size smaller than the laser spot) and all spectrawere
averaged to obtain a Raman spectrum that was representative
of each individual cell. Although measuring only single
spectra at single locations inside cells by Raman microspec-
trometers with lasers focused to micrometer sizes may
require shorter acquisition times, this approach is not appro-
priate for these cells due to their high spectral variability.CONCLUSIONS
We have demonstrated that RMS combined with multivar-
iate analysis (PCA) can be used with high accuracy forBiophysical Journal 100(1) 251–259
258 Pascut et al.label-free phenotypic identification of CMs derived from
hESCs. During measurements, the cells were maintained
under sterile physiological conditions and experimental
conditions were optimized to ensure that the cells incurred
no damage. We developed a beating-frequency analysis to
study individual cells, and the results showed that laser irra-
diation at 785 nm did not cause changes in the beating
frequency.
We developed a PCA model using Raman spectra of 50
CMs and 40 non-CMs within the same heterogeneous pop-
ulations as derived from hESCs. The phenotype of each
individual cell was confirmed as CM or non-CM by immu-
nofluorescence staining for a-actinin. The PCA model using
the scores of the first PC (65% variance captured) showed
that even for highly specific regimes (target 100% speci-
ficity), RMS can discriminate CMs from other phenotypes
with >97% specificity and >96% sensitivity. Furthermore,
these values did not vary for three CV algorithms
(70/30%, 80/20%, and LOOCV), demonstrating the robust-
ness of the technique.
The Raman bands identified in the PCA model indicated
that the spectral differences between CMs and non-CMs
were mainly attributed to glycogen and myofibrils. To
advance this assignment, we compared Raman spectral
images corresponding to the selected Raman bands identified
in the PCA loadings with the immunostaining of myofibrils
and glycogen. The similarity between the Raman spectral
images and glycogen-rich regions suggests that glycogen
makes a higher contribution to the spectral markers than
the myofibrils. However, further studies are under way to
compare the spectral markers with the Raman spectra of
myofibril proteins purified directly from hESC-derivedCMs.
Although this study focuses on hESC-derived CMs, the
results demonstrate the potential of RMS for enabling
noninvasive phenotypic identification of hESC progeny.
Such label-free, noninvasive analytical techniques can be
further developed to aid in the separation and purification
of cell populations as required for medical applications
such as cell therapy and regenerative medicine. However,
the long acquisition times as described in this work are
not yet practical for such applications. Therefore, further
developments in sampling methods, such as laser beam
expansion using low numerical objectives or line scanning,
are required to reduce measurement times and increase the
cell-sorting speed. In addition, the ability to noninvasively
monitor time-dependent molecular changes in live hESCs
during differentiation may also have a huge beneficial
impact on the refinement and standardization of protocols
to efficiently differentiate pluripotent SCs toward desired
phenotypes.SUPPORTING MATERIAL
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